The application of human natural polyclonal IgG-antibodies to Thomsen-Friedenreich epitope (TFE) for evaluation of TFE expression in cancer-associated mucins
Ep. Smorodin et al., The application of human natural polyclonal IgG-antibodies to Thomsen-Friedenreich epitope (TFE) for evaluation of TFE expression in cancer-associated mucins, EXP ONCOL, 22(1-2), 2000, pp. 44-47
Thomsen-Friedenreich epitope (TFE) - specificity of natural polyclonal anti
-TF Ige antibodies purified from cancerous sera, human monoclonal anti-TF I
gM (TF1), and peanut agglutinin (PNA) in relation to mucin and tumor extrac
ts obtained from cancer patients was investigated. The inhibition assay in
ELISA with synthetic TF-polyacrylamide showed a different anti-TF IgG antib
ody-binding with cancer-associated mucins that appeared to be connected wit
h TFE expression and presentation. The mucin and three of ten tumor extract
s were bound with anti-TF IgG significantly (up to 100% inhibition at conce
ntrations equal to or above 33 mg/ml). The desialylation of faintly reacted
tumor extract did not enhance its reactivity with anti-TF IgG antibodies w
hile PNA binding strongly increased. The intact extracts (n = 4) did not re
act with TF1. Human natural anti-TF IgG antibodies purified by immunoadsorp
tion on synthetic TF-PAA-MPG can be used for evaluation of TFE expression i
n mucins.